209 related articles for article (PubMed ID: 21468687)
1. Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas.
Kretschmer C; Conradi A; Kemmner W; Sterner-Kock A
Cell Oncol (Dordr); 2011 Oct; 34(5):419-34. PubMed ID: 21468687
[TBL] [Abstract][Full Text] [Related]
2. Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitro and in vivo.
Mauel S; Kruse B; Etschmann B; von der Schulenburg AG; Schaerig M; Stövesand K; Wilcken B; Sterner-Kock A
APMIS; 2007 Jun; 115(6):687-700. PubMed ID: 17550376
[TBL] [Abstract][Full Text] [Related]
3. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
[TBL] [Abstract][Full Text] [Related]
4. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
6. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
8. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
[TBL] [Abstract][Full Text] [Related]
9. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.
Ramamoorthy S; Tufail R; Hokayem JE; Jorda M; Zhao W; Reis Z; Nawaz Z
Breast Cancer Res Treat; 2012 Feb; 132(1):97-108. PubMed ID: 21553290
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
[TBL] [Abstract][Full Text] [Related]
13. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
Caruso JA; Karakas C; Zhang J; Yi M; Albarracin C; Sahin A; Bondy M; Liu J; Hunt KK; Keyomarsi K
Breast Cancer Res; 2014; 16(6):3417. PubMed ID: 25551582
[TBL] [Abstract][Full Text] [Related]
14. Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability.
Su CT; Huang JW; Chiang CK; Lawrence EC; Levine KL; Dabovic B; Jung C; Davis EC; Madan-Khetarpal S; Urban Z
Hum Mol Genet; 2015 Jul; 24(14):4024-36. PubMed ID: 25882708
[TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.
Bertagnolo V; Grassilli S; Volinia S; Al-Qassab Y; Brugnoli F; Vezzali F; Lambertini E; Palomba M; Piubello Q; Orvieto E; Natali C; Piva R; Croce CM; Capitani S
Mol Carcinog; 2019 May; 58(5):708-721. PubMed ID: 30582225
[TBL] [Abstract][Full Text] [Related]
16. PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.
Tian M; Schiemann WP
FASEB J; 2010 Apr; 24(4):1105-16. PubMed ID: 19897661
[TBL] [Abstract][Full Text] [Related]
17. Latent transforming growth factor β-binding protein 4 is downregulated in esophageal cancer via promoter methylation.
Bultmann I; Conradi A; Kretschmer C; Sterner-Kock A
PLoS One; 2013; 8(5):e65614. PubMed ID: 23741501
[TBL] [Abstract][Full Text] [Related]
18. [Notch1 mRNA and protein expression in human breast cancer and normal mammary gland tissues].
Hua BL; Fu XG; Hu WH; Yin L; Kang XL; Li HA; Jiang JF; Li F
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):806-9. PubMed ID: 20193454
[TBL] [Abstract][Full Text] [Related]
19. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
[TBL] [Abstract][Full Text] [Related]
20. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
Reinholz MM; Iturria SJ; Ingle JN; Roche PC
Breast Cancer Res Treat; 2002 Jun; 74(3):255-69. PubMed ID: 12206515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
